These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18463913)

  • 1. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.
    Allen MR; Reinwald S; Burr DB
    Calcif Tissue Int; 2008 May; 82(5):354-60. PubMed ID: 18463913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
    Allen MR; Burr DB
    J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2008 May; 66(5):987-94. PubMed ID: 18423290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
    Allen MR; Kubek DJ; Burr DB
    J Bone Miner Res; 2010 Jan; 25(1):98-105. PubMed ID: 19580463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
    Allen MR; Burr DB
    Osteoporos Int; 2008 Jan; 19(1):95-9. PubMed ID: 17710353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
    PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.
    Diab T; Allen MR; Burr DB
    Osteoporos Int; 2009 Apr; 20(4):647-52. PubMed ID: 18716822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Jacob DS; Johnston CC; Burr DB
    Bone; 2001 Sep; 29(3):271-8. PubMed ID: 11557372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.
    Tang SY; Allen MR; Phipps R; Burr DB; Vashishth D
    Osteoporos Int; 2009 Jun; 20(6):887-94. PubMed ID: 18850239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
    Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib.
    Mashiba T; Mori S; Burr DB; Komatsubara S; Cao Y; Manabe T; Norimatsu H
    J Bone Miner Metab; 2005; 23 Suppl():36-42. PubMed ID: 15984412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs.
    Burr DB; Liu Z; Allen MR
    Bone; 2015 Feb; 71():58-62. PubMed ID: 25445446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
    Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
    Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
    Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
    Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.
    Luo TD; Allen MR
    Bone; 2013 Sep; 56(1):199-203. PubMed ID: 23774445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate.
    Bajaj D; Geissler JR; Allen MR; Burr DB; Fritton JC
    Bone; 2014 Jul; 64():57-64. PubMed ID: 24704262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.